Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Antimicrob Chemother ; 74(3): 675-681, 2019 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-30535190

RESUMO

BACKGROUND: Owing to its antibacterial properties, ceftaroline could be attractive for prevention or treatment of bacterial post-neurosurgical meningitis/ventriculitis. However, few data are available concerning its meningeal concentrations. OBJECTIVES: To investigate ceftaroline CSF pharmacokinetics in ICU patients with an external ventricular drain (EVD). METHODS: Patients received a single 600 mg dose of ceftaroline as a 1 h intravenous infusion. Blood and CSF samples were collected before and 0.5, 1, 3, 6, 12 and 24 h after the end of the infusion. Concentrations were assayed in plasma and CSF by LC-MS/MS. A two-step compartmental pharmacokinetic analysis was conducted. Ceftaroline plasma data were first analysed, and thereafter plasma parameters estimated and corrected for protein binding of 20% were fixed to fit unbound CSF concentrations. In the final model, parameters for both plasma and CSF data were simultaneously estimated. RESULTS: Nine patients with an EVD were included. The Cmax was 18.29 ± 3.33 mg/L in plasma (total concentrations) and at 0.22 ± 0.17 mg/L in CSF (unbound concentration). The model-estimated CSF input/CSF output clearance ratio was 9.4%, attesting to extensive efflux transport at the blood-CSF barrier. CONCLUSIONS: Ceftaroline CSF concentrations are too low to ensure prophylactic protection against most pathogens with MICs between 1 and 2 mg/L, owing to its limited central distribution.


Assuntos
Antibacterianos/farmacocinética , Cefalosporinas/farmacocinética , Ventrículos Cerebrais/cirurgia , Líquido Cefalorraquidiano/metabolismo , Drenagem , Procedimentos Neurocirúrgicos , Adolescente , Adulto , Idoso , Antibacterianos/administração & dosagem , Cefalosporinas/administração & dosagem , Ventriculite Cerebral/tratamento farmacológico , Ventriculite Cerebral/etiologia , Ventriculite Cerebral/prevenção & controle , Cromatografia Líquida , Feminino , Humanos , Infusões Intravenosas , Unidades de Terapia Intensiva , Masculino , Meningites Bacterianas/tratamento farmacológico , Meningites Bacterianas/etiologia , Meningites Bacterianas/prevenção & controle , Pessoa de Meia-Idade , Modelos Teóricos , Procedimentos Neurocirúrgicos/efeitos adversos , Procedimentos Neurocirúrgicos/métodos , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/prevenção & controle , Espectrometria de Massas em Tandem , Adulto Jovem , Ceftarolina
2.
Presse Med ; 31(11): 498-502, 2002 Mar 23.
Artigo em Francês | MEDLINE | ID: mdl-11963376

RESUMO

OBJECTIVES: To investigate the risk factors for the acquisition (infection and/or colonization) of Pseudomonas aeruginosa, which is frequently associated with nosocomial infections, in a surgical intensive care unit in Dijon. METHOD: A retrospective case-control study was performed on 57 cases matching with 114 controls, between December 1996 and February 1999. The statistical method used was a conditional multiple logistic regression model. RESULTS: Three groups of variables were studied (patient characteristics--invasive procedures--previous administration of antibiotics). The multiple logistic regression analysis confirmed 3 risk factors: duration of sedation, infection with another bacteria and cranio-encephalic trauma. These factors are commonly involved in nosocomial infections. CONCLUSION: This study confirms the interest of infection control measures and the prevention of nosocomial infections, especially in cranio-encephalic trauma. The hypothetical relationship between acquisition of Pseudomonas aeruginosa and previous administration of antibiotics was not confirmed. A more powerful study would perhaps specify this relationship.


Assuntos
Infecção Hospitalar , Unidades de Terapia Intensiva , Infecções por Pseudomonas/etiologia , Pseudomonas aeruginosa/patogenicidade , Adulto , Idoso , Anestesia Geral , Antibacterianos/uso terapêutico , Estudos de Casos e Controles , Traumatismos Craniocerebrais/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Pseudomonas/patologia , Estudos Retrospectivos , Fatores de Risco , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...